Literature DB >> 6626393

Long term transvenous ventricular pacing in adults with congenital abnormalities of the heart and great arteries.

D E Ward, B Clarke, P M Schofield, S Jones, K Dawkins, D Bennett.   

Abstract

Improved techniques of transvenous pacing have made it possible to use this approach in various congenital cardiac abnormalities. Transvenous active fixation pacing leads were implanted in seven patients aged 15 to 81 years with abnormal venous, atrioventricular, or ventriculoarterial connections with successful ventricular pacing.

Entities:  

Mesh：

Year:  1983        PMID： 6626393      PMCID： PMC481418          DOI： 10.1136/hrt.50.4.325

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


  6 in total

1.  Three-year clinical experience with a new endocardial screw-in lead with introduction protection for use in the atrium and ventricle.

Authors:  H J Bisping; J Kreuzer; H Birkenheier
Journal:  Pacing Clin Electrophysiol       Date:  1980-07       Impact factor: 1.976

2.  The use of active fixation electrodes for permanent endocardial pacing via a persistent left superior vena cava.

Authors:  K J Hellestrand; D E Ward; R S Bexton; A J Camm
Journal:  Pacing Clin Electrophysiol       Date:  1982-03       Impact factor: 1.976

3.  Ten-year experience of 359 epicardial pacemaker systems: complications and results.

Authors:  P J Oldershaw; M G Sutton; D Ward; S Jones; G A Miller
Journal:  Clin Cardiol       Date:  1982-10       Impact factor: 2.882

4.  Use of subclavian vein for permanent cardiac pacing.

Authors:  G P McNeill; N C Taylor
Journal:  Br Heart J       Date:  1978-02

5.  Long-term endocardial atrial pacing in children with postoperative bradycardia-tachycardia syndrome and limited ventricular access.

Authors:  M D McGoon; J D Maloney; D C McGoon; G K Danielson
Journal:  Am J Cardiol       Date:  1982-05       Impact factor: 2.778

6.  Cardiac pacing in children.

Authors:  D E Ward; M Signy; P Oldershaw; S Jones; E A Shinebourne
Journal:  Arch Dis Child       Date:  1982-07       Impact factor: 3.791
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.